Center for Outcomes Research and Economic Evaluation for Health (C2H), National Institute of Public Health, 2-3-6 Minami, Wako-shi, Saitama, 351-0197, Japan.
Department of Clinical Genomics & Pediatrics, Saitama Medical University, 38 Moro Hongo Moroyama Iruma-Gun, Saitama, 350-0495, Japan.
Qual Life Res. 2024 Dec;33(12):3323-3333. doi: 10.1007/s11136-024-03775-0. Epub 2024 Sep 4.
PURPOSE: Inborn errors of metabolism (IEM) are known with poor long-term health concerns; however, the health-related quality of life (HRQoL) and the burden placed on families remain unclear. This study investigated the self- and proxy-reported HRQoL of pediatric patients with IEM with or without developmental disabilities and the burden placed on their caregivers. METHODS: Patients with IEM aged 8-15 years and their caregivers were asked to respond to the Pediatric Quality of Life Inventory (PedsQL), EuroQoL five-dimension questionnaire for younger populations (EQ-5D-Y), and Japanese version of the Zarit Caregiver Burden Interview (J-ZBI). We compared EQ-5D-Y scores with matched EQ-5D-Y population norms. Intraclass correlation coefficients (ICC) for self and proxy HRQoL scores of those without developmental disabilities were calculated. Correlation coefficients of HRQoL proxy responses with J-ZBI score were estimated. RESULTS: We included 66 patients with IEM (mean age, 11.5 years; males, 41.2%) in the study. The mean (± standard deviation) EQ-5D-Y scores without and with developmental disabilities were 0.957 (± 0.071) and 0.821 (± 0.175), respectively. The EQ-5D-Y scores significantly increased compared with the reference values (p < 0.01, effect size = 0.337). The ICC values were 0.331 and 0.477 for the EQ-5D-Y and PedsQL scores, respectively. HRQoL proxy scores had strong negative correlations with J-ZBI scores. CONCLUSION: The HRQoL of patients with IEM without developmental disabilities in our study was similar to that of the general Japanese population. The HRQoL of patients with IEM with developmental disabilities was low and associated with a tendency towards an increased burden of care.
目的:先天性代谢缺陷(IEM)已知存在长期健康问题;然而,患者的健康相关生活质量(HRQoL)和家庭负担仍不清楚。本研究调查了有无发育障碍的 IEM 儿科患者的自我和代理报告的 HRQoL 以及对其照顾者的负担。
方法:8-15 岁的 IEM 患者及其照顾者被要求回答儿童生活质量问卷(PedsQL)、适用于年轻人群的欧洲五维健康量表(EQ-5D-Y)和日本版 Zarit 照顾者负担量表(J-ZBI)。我们将 EQ-5D-Y 评分与匹配的 EQ-5D-Y 人群正常值进行了比较。计算了无发育障碍患者自我和代理 HRQoL 评分的组内相关系数(ICC)。估计了 HRQoL 代理反应与 J-ZBI 评分的相关系数。
结果:我们纳入了 66 名 IEM 患者(平均年龄 11.5 岁;男性占 41.2%)。无发育障碍和有发育障碍的患者的平均(±标准差)EQ-5D-Y 评分分别为 0.957(±0.071)和 0.821(±0.175)。EQ-5D-Y 评分明显高于参考值(p<0.01,效应量=0.337)。EQ-5D-Y 和 PedsQL 评分的 ICC 值分别为 0.331 和 0.477。HRQoL 代理评分与 J-ZBI 评分呈强烈负相关。
结论:本研究中无发育障碍的 IEM 患者的 HRQoL 与日本一般人群相似。有发育障碍的 IEM 患者的 HRQoL 较低,且与照顾负担增加的趋势相关。
Health Qual Life Outcomes. 2017-1-21
Health Qual Life Outcomes. 2020-5-24
Mediterr J Hematol Infect Dis. 2020-7-1
Pharmacoeconomics. 2021-11
Health Qual Life Outcomes. 2021-2-5
Ann Transl Med. 2018-12